Neonatal Pulmonology: Bronchopulmonary Dysplasia

Moderator(s)

• 

  Trent Tipple, MD

  Professor and Section Chief
  Pediatrics
  University of Oklahoma
  Oklahoma City, Oklahoma, United States
• 

  Anantha Harijith, MD, MRCP(UK)

  Associate Professor of Pediatrics
  Pediatrics
  UH Rainbow Babies and Children's Hospital Division of Pediatrics
  Cleveland, Ohio, United States

Presentations:

• 4:30 PM – 4:45 PM US CT

  The Effect of Serotonin Depletion on Hypoxia Induced Neonatal Murine Pulmonary Hypertension and Bronchopulmonary Dysplasia
  

  Presenter: Danielle Roberts, MD – University of Colorado - Anschutz Medical Campus
• 4:45 PM – 5:00 PM US CT

  Endothelial Adenosine Monophosphate-Activated Protein Kinase-alpha 1 (AMPKα1) Deficiency Potentiates Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia (BPD) and Pulmonary Hypertension (PH)
  

  Presenter: Ahmed Elsaie, MD – Baylor College of Medicine
• 5:00 PM – 5:15 PM US CT

  AMPK activator AICAR attenuates pro-inflammatory signaling in alveolar macrophages and improves alveolarization in a murine model of bronchopulmonary dysplasia
  

  Presenter: Sourabh Soni, PhD – Brigham and Women's Hospital, Harvard Medical School
• 5:15 PM – 5:30 PM US CT

  Mesenchymal Stem Cell (MSC) Mitochondrial Dysfunction Predicts Risk for Bronchopulmonary Dysplasia (BPD) in Extremely Low Birth Weight (ELBW) Infants
  

  Presenter: Snehashis Hazra, MBBS, MD – University of Alabama at Birmingham
• 5:30 PM – 5:45 PM US CT

  Increased Airway Expression of FAM13A Protein in ELBWs with BPD
  

  Presenter: Virginia Kaldas, MBBCh – Maria Fareri Children's Hospital